The fraction of a drug dose that reaches the systemic circulation unchanged, also indicated by the area under the curve (AUC) in a pharmacokinetic plot post-administration of a drug.
Sponsored by • 47 biobetter
A biologic that has an improved profile in terms of safety or efficacy, or both, compared to a biologic with a similar mode of action.
Neuropharmacology DMPK Toxicology Bioanalysis
Translational Medicine Clinical Development IND Program Management
The path to getting a medicine to the clinic is long and winding. To navigate it successfully requires teamwork and collaboration each step of the way.